跳至主要内容
临床试验/NCT02065778
NCT02065778撤回1 期

A Clinical Study of Autologous Bone Marrow Mononuclear Cells Intrathecal Transplantation in Chronic Stroke

Neurogen Brain and Spine Institute2 个研究点 分布在 1 个国家开始时间: 2008年12月最近更新:
适应症
干预措施

试验速览

阶段
1 期
状态
撤回
试验地点
2
主要终点
Functional Independence Measure

研究概览

简要总结

The purpose of this study was to study the safety and effect of stem cell therapy on the functional recovery in patients with chronic stroke.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • males and females
  • above 18 years of age
  • diagnosed as stroke by clinical and MRI findings

排除标准

  • presence of respiratory distress
  • presence of acute infections such as Human Immunodeficient Virus/Hepatitis B Virus/Hepatitis C Virus
  • malignancies
  • acute medical conditions such as respiratory infection, fever
  • hemoglobin less than 8
  • bleeding tendency
  • bone marrow disorder
  • left ventricular ejection fraction < 30%
  • pregnancy or breastfeeding

研究组 & 干预措施

Stem Cells

Experimental

autologous bone marrow mononuclear cell transplantation

干预措施: Autologous bone marrow mononuclear cell transplantation (Biological)

结局指标

主要结局

Functional Independence Measure

时间窗: 6 months

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验